{"id":"routine-continuous-cluster-of-alutard-sq","safety":{"commonSideEffects":[{"rate":null,"effect":"Local injection site reactions (erythema, swelling, pruritus)"},{"rate":null,"effect":"Systemic allergic reactions"},{"rate":null,"effect":"Anaphylaxis"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Alutard SQ works by administering increasing doses of allergen extract subcutaneously to induce immune tolerance. This process shifts the immune response from IgE-mediated (allergic) to IgG-mediated (protective) antibodies, and increases regulatory T cells, thereby reducing allergic symptoms upon natural allergen exposure.","oneSentence":"Alutard SQ is an allergen immunotherapy product that desensitizes patients to specific allergens through gradual dose escalation.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:06:19.009Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Allergic rhinitis and/or allergic asthma caused by specific allergens (e.g., pollen, dust mites, animal dander)"}]},"trialDetails":[{"nctId":"NCT04929093","phase":"PHASE4","title":"Novel Dose Adjustment Schedule for Late Injection in SCIT in AR","status":"COMPLETED","sponsor":"Beijing Tongren Hospital","startDate":"2020-06-11","conditions":"Allergic Rhinitis, Immunotherapy","enrollment":102}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Routine continuous cluster of Alutard SQ","genericName":"Routine continuous cluster of Alutard SQ","companyName":"Beijing Tongren Hospital","companyId":"beijing-tongren-hospital","modality":"Biologic","firstApprovalDate":"","aiSummary":"Alutard SQ is an allergen immunotherapy product that desensitizes patients to specific allergens through gradual dose escalation. Used for Allergic rhinitis and/or allergic asthma caused by specific allergens (e.g., pollen, dust mites, animal dander).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}